Ashish Kumar, MD Profile Banner
Ashish Kumar, MD Profile
Ashish Kumar, MD

@Ashish_Kumar_MD

Followers
841
Following
1,056
Media
44
Statuses
816

Cardiology 🫀 Fellow @MayoCVfellows | IM @ClevelandClinic Akron General | Cardiac Clinical Outcome Researcher🫀| R & STATA| Bioethics|🇮🇳🇺🇸

Mayo Clinic, Rochester
Joined July 2019
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
Pinned Tweet
@Ashish_Kumar_MD
Ashish Kumar, MD
7 months
Finally, dream come true. Matched Mayo Clinic, MN for 🫀 fellowship. Bold. Forward. Unbound. Thank you @AnkurKalraMD @abhishek_mbbs for being an inspiration! Also thanking, @SarjuGanatraMD @SaurabhSDani @JohnStulakMD @MariamShariffMD @DrDeese99 #CardioTwitter #Match23
Tweet media one
47
12
405
@Ashish_Kumar_MD
Ashish Kumar, MD
7 months
Excited to join the @MayoCVFellows @MayoClinicCV family!
@MayoCVFellows
Mayo Clinic Rochester Cardiology Fellows
7 months
We're delighted to welcome the newest members of the @MayoCVFellows @MayoClinicCV family🫀! Congratulations to the newly matched fellows! We can't wait to greet you in Rochester in July 2024!
Tweet media one
7
12
164
3
4
65
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Read our article on “Advanced subspecialty 🫀 training in India in 2022: challenges and future directions” - For IC 🇮🇳🇮🇳 has only 11 programs with 28 positions - One for EP - None for advanced HF
Tweet media one
5
13
56
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Our study reporting gender differences in international ❤️guidelines authorship. Also read the accompanying editorial by Mary Cushman, MD. We reported a significant disparity in the inclusion of women on all national guideline committees.
Tweet media one
Tweet media two
4
15
53
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Meta-analysis comparing PCI with CABG for NSTE-ACS in patients with MV or LM disease 👉 Similar outcomes at 30 days 👉 However, PCI associate with ⬆️⬆️⬆️ higher MACE 🫀at long term follow-up #Cardiotwitter #MedTwitter #CABG
Tweet media one
Tweet media two
Tweet media three
1
11
50
@Ashish_Kumar_MD
Ashish Kumar, MD
7 months
Dr. @AnkurKalraMD , I have been equally fortunate and privileged to be mentored by role models like you. Your constant support and dedication throughout my match journey has been unparalleled!! Can’t thank you enough for being my mentor!!
@AnkurKalraMD
Ankur Kalra
7 months
Not often do we find individuals who match the intensity & the passion for clinical investigation, yearn to improve themselves with every manuscript, & quite frankly, end up teaching their mentors. It has been my honor & privilege to be part of your journey, @Ashish_Kumar_MD . 🎉
Tweet media one
6
8
112
2
1
44
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
🧘‍♀️🧘🧘‍♂️The Effect of Yoga on Cardiovascular Disease Risk Factors: A Meta-Analysis🧘🧘‍♀️🧘‍♂️ 👉 64 RCTs including a total of 16,797 participants 👉 Yoga therapy improved both systolic as well as diastolic blood pressure 👉 Improvement in BMI 👉 improvement hemoglobin A1c, LDL
Tweet media one
0
11
43
@Ashish_Kumar_MD
Ashish Kumar, MD
7 months
🫀Read our new publication “Heparin Dosing During Percutaneous Coronary Intervention and Obesity” ✅ Significant variability in dosing of heparin ✅ 💃received higher 1️⃣ weight adjusted heparin ✅ ⬇️weight adjusted heparin dose required in obese patients for target ACT.
Tweet media one
1
4
36
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Using a cohort of 972 HF patients, we reported RVSP ≥40 mm Hg compared with RVSP < 40 mm Hg were associated with; Higher rates of death☠️ [HR: 1.60, 95% CI: 1.22 – 2.09, P-value = 0.001] All-cause readmissions [HR: 1.37, 95% CI: 1.09 – 1.73, P-value = 0.008]
Tweet media one
Tweet media two
Tweet media three
2
8
37
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
Our Study; Predictors of Major Adverse Cardiovascular Events in Patients With Moderate Aortic Stenosis 👉 Substantial adverse events at follow-up. 👉 Predictors of adverse events 1️⃣ Elevated BNP 2️⃣ Diabetes 3️⃣ Elevated E/e’ 4️⃣ Atrial fibrillation
1
10
34
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
“𝑻𝒉𝒆 𝒃𝒖𝒓𝒈𝒆𝒐𝒏𝒊𝒏𝒈 𝑪𝑽𝑫 𝒆𝒑𝒊𝒅𝒆𝒎𝒊𝒄 𝒊𝒏 𝑰𝒏𝒅𝒊𝒂𝒏𝒔 – 𝒑𝒆𝒓𝒔𝒑𝒆𝒄𝒕𝒊𝒗𝒆𝒔 𝒐𝒏 𝒄𝒐𝒏𝒕𝒆𝒙𝒕𝒖𝒂𝒍 𝒇𝒂𝒄𝒕𝒐𝒓𝒔 𝒂𝒏𝒅 𝒑𝒐𝒕𝒆𝒏𝒕𝒊𝒂𝒍 𝒔𝒐𝒍𝒖𝒕𝒊𝒐𝒏𝒔”; published in 𝑻𝒉𝒆 𝑳𝒂𝒏𝒄𝒆𝒕- Regional Heath, Southeast Asia @LancetRH_SEAsia
Tweet media one
1
11
31
@Ashish_Kumar_MD
Ashish Kumar, MD
8 months
✅In the U.S. a total of 516 VF/VT were reported as an adverse event post SARS-CoV-2 targeted mRNA/ viral vector vaccination ✅The incidence was 0.76 per 1 million vaccination. ✅The number of VF/VT occurring were higher ≥ 7 days since vaccination and after the 2nd dose.
Tweet media one
3
11
32
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Watch the “CRM journal club” discussion of our study @CRMjournal ; ;July2022 issue; ; @AnkurKalraMD @raj20490 @MonilMajmundar @MariamShariffMD @safinmc
Tweet media one
0
9
29
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Meta-analysis of ProGlide Versus MANTA Vascular Closure Devices For Large-Bore Access Site Management; 1) Database search until August 27, 2021 2) Both VCDs have comparable outcomes with regard to risk of bleeding, vascular complications
Tweet media one
Tweet media two
2
8
28
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
“Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States”; Our study published in @JACCJournals 👉SVI had ⬆️ ⬆️ effect of Cardio-oncology related mortality, compared with cancer or CVD mortality alone;
Tweet media one
Tweet media two
Tweet media three
1
6
28
@Ashish_Kumar_MD
Ashish Kumar, MD
8 months
The meta-analysis of RCTs comparing surgical revascularization with best endovascular strategy among chronic limb threatening ischemia patients with infra-popliteal disease reported; 🚫 No difference in the rates of 1️⃣major adverse limb events plus mortality and; 2️⃣mortality
Tweet media one
3
5
25
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Gender and Racial/Ethnic Disparities in Award Distribution by Major Cardiovascular Societies From 2000 to 2021, work lead by ⭐️ @kinza7_iqbal ; Thank you @DrMarthaGulati ; @purviparwani & @ErinMichos
@kinza7_iqbal
Kinza Iqbal
2 years
Humbled to share my first JACC 📝 with the undisputed queens of cardiology @DrMarthaGulati @ErinMichos @purviparwani ! This analysis of the awardees of major 🫀 societies shows that most 🏆 continue to go to men (76%) and White individuals (75%).
Tweet media one
Tweet media two
7
33
165
1
6
25
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
Read our abstract titled "A Bayesian Multiple Treatment Comparisons Meta‐analysis of Antioxidant Micronutrient Supplements for Adult Critically Ill Patients" awarded the "International Poster of Distinction" at the ASPEN Nutrition Science & Practice Conference, 2021.
Tweet media one
2
0
23
@Ashish_Kumar_MD
Ashish Kumar, MD
11 months
👉 SGLT2-Inhibitors in patients with type 2 DM is associated with a lower risk of arrhythmia recurrence after AF ablation @SarjuGanatraMD @SaurabhSDani @SumanthKhadke @MyAkronGeneral @CleClinicHVTI @JACCJournals @MariamShariffMD @Sglt2inhibitorL @HRSonline
Tweet media one
Tweet media two
@SarjuGanatraMD
Sarju Ganatra, MD, FACC
11 months
Recurrent Afib after undergoing ablation is burdensome SGLT2i reduce the recurrent #afib after afib #ablation #EPeeps ⬇️ need of repeat cardioversion, antiarrhythmic & repeat ablations with #SGLT2i ⬇️ #HF , hospitalization & mortality @JACCJournals
Tweet media one
4
28
102
0
6
23
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
Sex Differences in Professional Introductions at the American College of Cardiology's Annual Scientific Session & Expo (ACC.22); @kinza7_iqbal @SS_Rathore07 @alishaque99 @farid_eisha @ayman_iqbal17 @MonilMajmundar @MariamShariffMD @JACCJournals @ACCinTouch @Cardiology
@AnkurKalraMD
Ankur Kalra
1 year
We reviewed all the videos of the @ACCinTouch Annual Scientific Session & Expo (ACC.22) to identify participants as either “introducers” or “speakers,” and identify implicit sex bias in introductions at the ACC.22–out now in @JACCJournals #JACCAdvances
Tweet media one
6
11
60
1
9
22
@Ashish_Kumar_MD
Ashish Kumar, MD
6 months
🔥🔥Hot of the press; A systematic review and meta‐analysis of new‐onset atrial fibrillation in the context of COVID‐19 infection ; by @SS_Rathore07 and @abhishek_mbbs ; ✅ COVID-19 patients with NOAF had a higher risk of severe disease; mortality.
1
3
18
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Dexmedetomidine Reduces Incidences of Ventricular Arrhythmias in Adult Patients; -Significant reduction of the overall incidence of ventricular arrhythmias (RR 0.35, 95% CI 0.16, 0.76) -Decreased the risk of VT -No significant difference in mortality
Tweet media one
Tweet media two
1
3
18
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Inequities in Country- and Gender-Based Authorship Representation in Cardiology-Related Cochrane Reviews ‼️High income countries were significantly over-represented compared with low income countries ‼️Top five countries were; 🇬🇧, 🇨🇦, 🇨🇳, 🇺🇸, 🇦🇺
Tweet media one
1
6
17
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
“One-year outcomes of catheter ablation for atrial fibrillation in young patients [< 50 years]” 👉 Reduced 1-year AF readmissions 👉 Reduced 1-year all cause readmission @andrewtsengmd @abhishek_mbbs @harsh_cardio @DrDeese99
Tweet media one
0
7
18
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Read our article on 🫀“Outcomes of concomitant aortic valve procedures and left ventricular assist device implantation” 👉 Concurrent AVPs were associated with higher short-term mortality ☠️☠️ and reduced long-term survival 💀💀;
Tweet media one
4
2
18
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
🫀Prognostic value of initial electrocardiography in predicting long-term all-cause mortality in COVID-19🫀; - AF and Sinus tachycardia reported ⬆️ long-term mortality; - Right axis deviation also reported ⬆️ long-term mortality
Tweet media one
1
1
18
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Impact of CKD on In-Hospital Outcomes of Acute Limb Ischemia Undergoing Endovascular Therapy; ‼️ In-hospital mortality 🏨 ☠️was significantly ⬆️ in a graded way in advanced CKD groups; ‼️ Complications ⬆️ in advanced CKD groups
1
4
15
@Ashish_Kumar_MD
Ashish Kumar, MD
7 months
✅ Structured Program for Weight Loss in Heart Failure Patients, Read our new research letter now published in @JACCJournals Advances.
@AnkurKalraMD
Ankur Kalra
7 months
Operationalization of a Cardiology-Driven Obesity Clinic—First International Report outside of the Clinical Trials by @Vijayrao7474 et al. in @JACCJournals . @makeadentorg Aavishqaar Fund provided illustrative & statistical support for this study.
Tweet media one
Tweet media two
3
14
46
0
3
15
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
Thank you so much @AnkurKalraMD for being an incredible mentor. You always inspire and push me to be better each day. The feat is more you than me. Thank you for the great opportunity and hoping to learn more each day. #cardiotwitter
@AnkurKalraMD
Ankur Kalra
4 years
Also shout out to @MyAkronGeneral Section of Cardiovascular Research, Heart, Vascular and Thoracic Department’s first research fellow, @DrKumar_A , who’s been incredibly productive in 2020, and produced some great science.
0
0
8
1
1
15
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
Article In Press “Validating and implementing cardiac telemetry for continuous QTc monitoring: A novel approach to increase healthcare personnel safety during the COVID-19 pandemic”
1
4
14
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
☝️An updated meta-analysis reporting benefits of IVUS or OCT in patients undergoing DES implantation; ✌️Choice should be based on resources and experience.
@MariamShariffMD
Mariam Shariff, MD
2 years
Our study demonstrated ▪️Angio was associated with ⬆️ MACE, TVR & 🫀Mortality vs IVUS ▪️OCT has similar MACE, TVR & 🫀mortality vs IVUS ▪️Similar odds of MI and all-cause ☠️ Angio vs IVUS vs OCT @MyJSCAI @JohnStulakMD @AnkurKalraMD @Ashish_Kumar_MD @MayoClinicCVS #CardioTwitter
1
4
26
1
3
14
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
Thank you🙏🏻
@MariamShariffMD
Mariam Shariff, MD
1 year
So proud of @Ashish_Kumar_MD for winning the “Resident teacher of the Year” award. You are indeed a fabulous teacher to everyone. I’ve been quite lucky as well. #MedTwitter #Teacheroftheyear
Tweet media one
2
1
44
0
0
14
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years 👉NMR-r was associated with improved outcomes,overall. NNT= 47 👉No benefit without serious co-morbidities. @jeremyfaust @SarjuGanatraMD @SaurabhSDani
1
5
12
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
⚠️Our study adds to the limited literature of chemotherapy induced right ventricular cardiomyopathy; ⚠️Chemotherapy ⬇️RVEF ⬇️RVFAC ⬇️RVFWLS #CardioTwitter #Cardionc #Cardiology @MyAkronGeneral @CleClinicHVTI @Cardioonc_bot
1
1
11
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
Our study extrapolated that in HFpEF, anemia is associated with statistically significant higher all-cause mortality and hospitalization. @MonilMajmundar @MariamShariffMD @raj20490 @devina_adalja @BotCardiology #HeartFailure #CardioEd #Cardiology #Anemia
2
3
12
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
Hospital Procedural Volume Predicts Short-term Outcomes for Patients Undergoing Procedures Requiring Large-bore Access #ACC23
@AnkurKalraMD
Ankur Kalra
1 year
#ACC2023 @ESC_Journals #EHJ Simultaneous Publication: We observed nonlinear declining trends for all-cause in-hospital mortality, vascular complications, and 30-day readmission rates against the hospital’s annual large-bore procedural (LBP) volume on
Tweet media one
Tweet media two
1
12
30
0
2
10
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
CA is associated with lower in‐hospital adverse procedural outcomes as compared with SA among HFrEF hospitalizations with AF. @raj20490 @DrShariff_M @devina_adalja @SarasVallabhMD #MedTwitter #cardiotwitter #EP
Tweet media one
3
2
11
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
3
1
11
@Ashish_Kumar_MD
Ashish Kumar, MD
5 years
A great way to start my day with absolute motivation, especially for a budding researcher like me. The vital keys are motivation, enthusiasm and persistence to excel in the field of research. @AnkurKalraMD @GreggWStone @radcliffeCARDIO
@radcliffeCARDIO
Radcliffe Cardiology
5 years
#RCpodcast 🎙 Episode 15: @GreggWStone on becoming a clinician, trialist and educator hosted by @AnkurKalraMD Listen here or on Apple Podcast, iTunes and Spotify! @MountSinaiHeart @IcahnMountSinai @crfheart #CardioTwitter #MedEd #MedStudent
Tweet media one
0
6
6
1
2
10
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
@Dr_MONIL @raj20490 @SidakpalP @AnkurKalraMD @tavrkapadia @SarasVallabhMD Meta-analysis of 19 observational studies reported no difference in the risk of 30-day mortality, 1-year mortality, 30-day cardiovascular mortality, major/life-threatening bleeding, permanent pacemaker implantation, device success between BAS and TAS patients undergoing TAVI.
1
1
9
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
Read our meta analysis published on the utility of STE in predicting subclinical myocardial involvement in patients with sarcoidosis @DeveshRaiMD @thakkar_samarth @navinnanda1
Tweet media one
1
0
9
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
👉 We used the CDC WONDER database for the present analysis; 👉Effect of SVI more pronounced in minority communities; 👉The present report can be used for targeted policy implementation.
Tweet media one
1
3
9
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
Telemetry-based QTc measurements highly correlated with QTc values derived from ECG, with correlation coefficients of 0.74, 0.79, 0.85 (individual operators), and 0.84 (mean of all operators).
Tweet media one
Tweet media two
Tweet media three
1
0
9
@Ashish_Kumar_MD
Ashish Kumar, MD
8 months
@CRMjournal
CRMjournal
8 months
Just accepted in @CRMjournal + @ELS_Cardiology ! Surgical revascularization versus best endovascular therapy for #CLI with infra-popliteal disease by Ashish Kumar et al.
Tweet media one
0
3
6
0
4
8
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
Thank you Dr. @AnkurKalraMD for all the guidance.
@AnkurKalraMD
Ankur Kalra
3 years
When your mentee is on fire at the @AHAScience @AHAMeetings #AHA21 –keep up the great work, Dr. @Ashish_Kumar_MD !
2
0
29
1
0
8
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
The burgeoning cardiovascular disease epidemic in Indians – perspectives on contextual factors and potential solutions; @LancetRH_SEAsia @AnkurKalraMD
@thePHFI
Public Health Foundation of India (PHFI)
1 year
#Study I The burgeoning cardiovascular disease epidemic in Indians – perspectives on contextual factors and potential solutions @DrDPrabhakaran @drambujroy @PoornimaPrabha3 @drapjtweets #CardioTwitter #Cardiology #CVD
0
6
12
0
2
7
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
There were 806 women 💃💃, constituting 42.4% of all authors #CardioTwitter #wic #Cardiology #MedTwitter
0
0
8
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
Antioxidant Micronutrient Supplements for Adult Critically Ill Patients: A Bayesian Multiple Treatment Comparisons Meta-analysis @MariamShariffMD @MyAkronGeneral #MedTwitter #CriticalCare #Review
1
2
8
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
Endovascular reperfusion strategy for infra-popliteal chronic limb threatening ischaemia; our editorial @TheLancet We compare the results of the BASIL-2 trial, with that of the BEST-CLI and BASIL-1 (subgroups) and provide our take on the contradicting results. @AnkurKalraMD
@AnkurKalraMD
Ankur Kalra
1 year
Endovascular reperfusion strategy for infra-popliteal chronic limb threatening ischaemia—invited commentary on BASIL-2 trial, out now in @TheLancet .
Tweet media one
1
5
24
1
1
6
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Our study on MVR reported anterior/bileaflet had comparable outcomes with posterior repair; there was no difference in, ▪️Survival💀 ▪️Freedom from MR ▪️Freedom from Re-op🪡 Thank you @kinza7_iqbal @SS_Rathore07 for your work. Thank you @MariamShariffMD and @JohnStulakMD .
@MariamShariffMD
Mariam Shariff, MD
2 years
Our study on MVR shows comparable long term outcomes between anterior/bileaflet vs posterior repair🫀 Thank you for your mentorship ⁦ @JohnStulakMD ⁩ ⁦ @Ashish_Kumar_MD ⁩ ⁦ @MayoClinicCVS @kinza7_iqbal #CardioTwitter #CVSurg #MedTwitter
1
5
19
1
3
7
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
@AnkurKalraMD @MyAkronGeneral Thank you @AnkurKalraMD for your perpetual support, guidance and mentorship through this whole process. I am extremely grateful and lucky to have an amazing Mentor like you. I am looking forward to working directly under you as a resident and a research fellow.
1
0
7
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
•MitraClip in secondary MR reduces the risk of all-cause mortality. •MitraClip in secondary MR reduces the risk of readmission events. •MitraClip in high left ventricular end diastolic volume at baseline has poor outcome.
2
4
6
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
‼️ Read our article on outcomes of concomitant aortic valve procedures and LVAD implantation ‼️ @ArtifOrgans ; @kinza7_iqbal ; @MariamShariffMD ; @CleClinicHVTI
0
2
6
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
@AnkurKalraMD @HarshGMD @GaurangaMD @kalrahospitals @GrantReedMD @MonilMajmundar @NicoleMaeLao1 @makeadentorg @ShelleyWood2 @mmamas1973 @CurrProbsCardio To add to @AnkurKalraMD , #POPular TAVI trial found no benefit with addition of Clopidogrel to oral anticoagulation in patients with indication for anticoagulation, with clopidogrel group associated with higher bleeding.
1
2
6
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
Among non-ICU patients hospitalized with COVID-19 pneumonia complicated by AHRF, treatment with corticosteroid was associated with a significantly lower risk of the primary composite outcome of ICU transfer, intubation, or inhospital death.
@medrxivpreprint
medRxiv
4 years
Efficacy of Corticosteroids in Non-Intensive Care Unit Patients with COVID-19 Pneumonia from the New York Metropolitan region #medRxiv
2
6
6
1
2
5
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
According to study results, cases of broken heart syndrome have increased since the pandemic started via @tech2s @AnkurKalraMD @AhmadJabri8 @JAMANetworkOpen
0
2
6
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
The prognostic value of right ventricular systolic pressure (RVSP) in HF patients measured using transthoracic echocardiography as an alternative method to assess PH is not well established, with right heart catheterization most commonly used to quantify pulmonary hypertension.
1
0
6
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
@DBelardoMD Matched IM and interested in Cardiology.
1
1
5
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
Cardiac telemetry is a validated clinical tool for QTc monitoring that may serve an expanding role during the COVID-19 pandemic strengthened by its remote and continuous monitoring capability and ubiquitous presence throughout hospitals.
1
0
5
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
0
0
5
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
@Dr_MONIL @raj20490 @SidakpalP @AnkurKalraMD @tavrkapadia @SarasVallabhMD We used a novel method of supervised machine learning algorithms (k-means, DBSCAN, and GMM algorithm) to identify sub-clusters in our data and hence, identify the source of heterogeneity.
Tweet media one
2
1
5
@Ashish_Kumar_MD
Ashish Kumar, MD
3 years
@AnkurKalraMD @MyAkronGeneral @DrShariff_M Thank you @AnkurKalraMD for your kind words. Thank you for making work fun. The newly established Section of Cardiovascular Research, Heart, Vascular and Thoracic Department @MyAkronGeneral will scale heights under your guidance.
3
0
5
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
1
1
5
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
⛔️In this study using the CDC and BRFSS dataset, ⚠️we report long sleep duration to be a risk factor for atrial fibrillation and flutter(mortality).⛔️ @abhishek_mbbs @nandananavekar @JohnStulakMD @TheRhythmDoc #VirendSomers @MariamShariffMD @kinza7_iqbal
@JICE_EP
JICE
1 year
🚨New #FreeRead Article @JICE_EP Association of Sleep Duration w/ atrial fibrillation/flutter Mortality in United States: a cross-sectional analysis By @Ashish_Kumar_MD K Iqbal, @MariamShariffMD @JohnStulakMD @nandananavekar & A Deshmukh 🧐 #Epeeps
Tweet media one
Tweet media two
0
7
16
0
2
5
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
@gbiondizoccai @Dr_MONIL @raj20490 @SidakpalP @VinodThourani @SarasVallabhMD @tikal_kansara Considering the observational nature of most of the studies included we wanted to rule the possibility of p-hacking and publication bias using p curve analysis. Thank you @gbiondizoccai for your kind words.
1
1
5
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
Cleveland Clinic study: Rise in broken-heart syndrome caused by increased stress of coronavirus pandemic @AnkurKalraMD @AhmadJabri8 @JAMANetworkOpen
0
1
5
@Ashish_Kumar_MD
Ashish Kumar, MD
2 years
Thank you for your kind words @kinza7_iqbal , thank you @MariamShariffMD .
@kinza7_iqbal
Kinza Iqbal
2 years
Extremely honoured to co-author with the incredible @JohnStulakMD . All thanks to my amazing mentor @Ashish_Kumar_MD for his constant support and guidance! @SS_Rathore07
0
3
8
0
0
4
@Ashish_Kumar_MD
Ashish Kumar, MD
4 years
Congratulations! It was wonderful working with the team. @DeveshRaiMD @thakkar_samarth
@DeveshRaiMD
🥕Devesh Rai, MD🥕
4 years
Our new analysis in #echocadiography regarding the role of Speckle tracking echo in predicting myocardial involvement in patients with sarcoidosis. #EchoFirst @bbaibhav @SFeitell @MraoEP77 @mbsdo1 @vparikh2321 @thakkar_samarth @DrKumar_A
1
1
4
0
0
4
@Ashish_Kumar_MD
Ashish Kumar, MD
1 year
Mild aortic insufficiency following transcatheter aortic valve replacement: A systematic review and meta-analysis; 👉50% of patients undergoing TAVR develop mild AI postoperatively. 👉In 37% of patients, this persists in long term #tavr #CardioTwitter
0
0
4